437 related articles for article (PubMed ID: 14690302)
1. Relation of erythrocyte Na+-K+ ATPase activity and cholesterol and oxidative stress in patients with type 2 diabetes mellitus.
Konukoglu D; Kemerli GD; Sabuncu T; Hatemi H
Clin Invest Med; 2003 Dec; 26(6):279-84. PubMed ID: 14690302
[TBL] [Abstract][Full Text] [Related]
2. Reduction of erythrocyte (Na(+)-K+)ATPase activity in type 2 (non-insulin-dependent) diabetic patients with microalbuminuria.
Mimura M; Makino H; Kanatsuka A; Asai T; Yoshida S
Horm Metab Res; 1994 Jan; 26(1):33-8. PubMed ID: 8150421
[TBL] [Abstract][Full Text] [Related]
3. Effects of oxidative stress on the erythrocyte Na+,K+ ATPase activity in female hyperthyroid patients.
Konukoglu D; Yelke HK; Hatemi H; Sabuncu T
J Toxicol Environ Health A; 2001 Jun; 63(4):289-95. PubMed ID: 11437061
[TBL] [Abstract][Full Text] [Related]
4. Effects of proinsulin C-peptide on nitric oxide, microvascular blood flow and erythrocyte Na+,K+-ATPase activity in diabetes mellitus type I.
Forst T; De La Tour DD; Kunt T; Pfützner A; Goitom K; Pohlmann T; Schneider S; Johansson BL; Wahren J; Löbig M; Engelbach M; Beyer J; Vague P
Clin Sci (Lond); 2000 Mar; 98(3):283-90. PubMed ID: 10677386
[TBL] [Abstract][Full Text] [Related]
5. Hyperglycemia induced oxidative stress in type-1 and type-2 diabetic patients with and without nephropathy.
Dave GS; Kalia K
Cell Mol Biol (Noisy-le-grand); 2007 May; 53(5):68-78. PubMed ID: 17543235
[TBL] [Abstract][Full Text] [Related]
6. Effect of aldose reductase inhibitor (Ponalrestat) on erythrocyte Na,K-ATPase activity in non-insulin-dependent diabetic patients with polyneuropathy.
Umeda F; Noda K; Hashimoto T; Yamashita T; Nawata H
Diabetes Res; 1989 Nov; 12(3):125-9. PubMed ID: 2561396
[TBL] [Abstract][Full Text] [Related]
7. Transmembrane cationic fluxes in erythrocytes of diabetics and normal men.
Lijnen P; Fenyvesi A
Methods Find Exp Clin Pharmacol; 1994; 16(1):37-47. PubMed ID: 8164472
[TBL] [Abstract][Full Text] [Related]
8. Electrolytes and NA(+)-K(+)-ATPase: potential risk factors for the development of diabetic nephropathy.
Shahid SM; Mahboob T
Pak J Pharm Sci; 2008 Apr; 21(2):172-9. PubMed ID: 18390448
[TBL] [Abstract][Full Text] [Related]
9. Hypothesis: low Na/K-ATPase activity in the red cell membrane, a potential marker of the predisposition to diabetic neuropathy.
Raccah D; Gallice P; Pouget J; Vague P
Diabete Metab; 1992; 18(3):236-41. PubMed ID: 1327887
[TBL] [Abstract][Full Text] [Related]
10. Effects of metabolic control and vascular complications on indices of oxidative stress in type 2 diabetic patients.
Komosińska-Vassev K; Olczyk K; Olczyk P; Winsz-Szczotka K
Diabetes Res Clin Pract; 2005 Jun; 68(3):207-16. PubMed ID: 15936462
[TBL] [Abstract][Full Text] [Related]
11. The effects ex vivo and in vitro of insulin and C-peptide on Na/K adenosine triphosphatase activity in red blood cell membranes of type 1 diabetic patients.
Djemli-Shipkolye A; Gallice P; Coste T; Jannot MF; Tsimaratos M; Raccah D; Vague P
Metabolism; 2000 Jul; 49(7):868-72. PubMed ID: 10909997
[TBL] [Abstract][Full Text] [Related]
12. Effects of C-peptide on microvascular blood flow and blood hemorheology.
Forst T; Kunt T
Exp Diabesity Res; 2004; 5(1):51-64. PubMed ID: 15198371
[TBL] [Abstract][Full Text] [Related]
13. Serum E-selectin and erythrocyte membrane Na+K+ ATPase levels in patients with rheumatoid arthritis.
Yildirim K; Senel K; Karatay S; Sisecioglu M; Kiziltunc A; Ugur M; Akcay F
Cell Biochem Funct; 2005; 23(4):285-9. PubMed ID: 15515123
[TBL] [Abstract][Full Text] [Related]
14. [A study of Na(+)-K(+)-ATP ase activity in erythrocyte membrane from diabetic retinopathy patients].
He J; Qiu Y; Zhou X
Zhonghua Yan Ke Za Zhi; 1998 Nov; 34(6):421-3. PubMed ID: 11877243
[TBL] [Abstract][Full Text] [Related]
15. Association of hypoglutathionemia with reduced Na+/K+ ATPase activity in type 2 diabetes and microangiopathy.
Sampathkumar R; Balasubramanyam M; Tara C; Rema M; Mohan V
Mol Cell Biochem; 2006 Jan; 282(1-2):169-76. PubMed ID: 16317524
[TBL] [Abstract][Full Text] [Related]
16. C-peptide, Na+,K(+)-ATPase, and diabetes.
Vague P; Coste TC; Jannot MF; Raccah D; Tsimaratos M
Exp Diabesity Res; 2004; 5(1):37-50. PubMed ID: 15198370
[TBL] [Abstract][Full Text] [Related]
17. Impairment of sodium pump and Na/H exchanger in erythrocytes from non-insulin dependent diabetes mellitus patients: effect of tea catechins.
Rizvi SI; Zaid MA
Clin Chim Acta; 2005 Apr; 354(1-2):59-67. PubMed ID: 15748600
[TBL] [Abstract][Full Text] [Related]
18. Na,K-atpase alterations in diabetic rats: relationship with lipid metabolism and nerve physiological parameters.
Djemli-Shipkolye A; Coste T; Raccah D; Vague P; Pieroni G; Gerbi A
Cell Mol Biol (Noisy-le-grand); 2001 Mar; 47(2):297-304. PubMed ID: 11355004
[TBL] [Abstract][Full Text] [Related]
19. GM1 ganglioside prevents seizures, Na+,K+-ATPase activity inhibition and oxidative stress induced by glutaric acid and pentylenetetrazole.
Fighera MR; Royes LF; Furian AF; Oliveira MS; Fiorenza NG; Frussa-Filho R; Petry JC; Coelho RC; Mello CF
Neurobiol Dis; 2006 Jun; 22(3):611-23. PubMed ID: 16516483
[TBL] [Abstract][Full Text] [Related]
20. Plasma total homocysteine concentrations in obese and non-obese female patients with type 2 diabetes mellitus; its relations with plasma oxidative stress and nitric oxide levels.
Konukoğlu D; Serin O; Turhan MS
Clin Hemorheol Microcirc; 2005; 33(1):41-6. PubMed ID: 16037631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
